45 results, showing 21 to 40
This statement of differences was given to the ACCC on 13 November 2012 by NBN Co in respect to an access agreement entered into by NBN Co and multiple access seekers. This access agreement contains differences from a standard form of access agreement (SFAA) as published by NBN Co (the ‘Wholesale Broadband Agreement’).
On 12 December 2012, the ACCC consented to a variation of the section 87B Undertaking given by Pfizer Inc and Pfizer Australia Pty Ltd (together referred to as Pfizer) on 30 September 2009 (the Undertaking).
The ACCC accepted the Undertaking as part of its decision not to oppose Pfizer’s proposed acquisition of Wyeth Corp. Amongst other things, the Undertaking required the divestiture of Wyeth’s Fort Dodge Livestock Business to a purchaser approved by the ACCC (Virbac Group).
The Livestock Business comprised a number of pharmaceutical vaccines including the mycoplasma hypopneumoniae vaccine (M Hyo Swine Vaccines) which is manufactured overseas and imported into Australia for sale.
The Undertaking has been varied to remove the obligations relating to the transfer of the manufacture of the M Hyo Swine Vaccines to Virbac. Several clauses relating to the confidential obligations have also been varied.
The ACCC has accepted a section 87B Undertaking from Angela Delgiacco in respect of false or misleading representations made to consumers during the sale of an Indigenous artwork.
Angela Delgiacco admits that she contravened sections 18 and 29(I)(a) of the Competition and Consumer Act 2010 by, in relation to the painting titled 'Women's Hairstring Ceremony' (the Artwork), attributing:
a title to the Artwork which was commonly attributed to paintings by Makinti Napanangka rather than a title given to the Artwork by Makinti Napanangka; and
a date to the Artwork without knowledge of when the Artwork was painted.